|
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
|
2R01CA173481-06
|
$385,883
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Nanoparticle mediated microenvironmental targeting of CCL3 signaling for the treatment of acute myelogenous leukemia
|
1F31CA228391-01
|
$42,418
|
|
ACKUN-FARMMER, MARIAN
|
UNIVERSITY OF ROCHESTER
|
|
Mutagenesis and migration in glioblastoma cells
|
1R21CA220111-01A1
|
$179,240
|
|
AHN, EUN HYUN
|
UNIVERSITY OF WASHINGTON
|
|
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
|
5F30CA220847-02
|
$49,524
|
|
ALI, MOIEZ
|
DUKE UNIVERSITY
|
|
Profiling signaling activity and gene expression in single, pancreatic adenocarcinoma cells using CE-RNA-Seq
|
1R01CA224763-01A1
|
$575,272
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,652,758
|
$16,528
|
Alter, Blanche
|
DCEG (NCI)
|
|
Novel Molecular Therapies of Prostate Cancer
|
5P01CA140043-09
|
$1,222,825
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Tumor Plasticity
|
5R35CA220446-02
|
$1,140,000
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
|
5R01CA178610-05
|
$317,240
|
|
ALUMKAL, JOSHI
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The regulation of dendritic cell function by LMYC at steady state and during immune responses to cancer
|
1F31CA228240-01
|
$30,442
|
|
ANDERSON, DAVID
|
WASHINGTON UNIVERSITY
|
|
Defining the Transcriptional Regulation and Genomic Organization of FAIM3 and PIGR, Human Ig Receptors Involved in Immunity, Auto-Immune Disease, and Lymphoma
|
5F31CA221012-02
|
$30,434
|
|
ANDREWS, JARED
|
WASHINGTON UNIVERSITY
|
|
Protease activated receptor-2 (PAR-2) signaling and metastatic ovarian cancer
|
5R01CA196988-02
|
$353,419
|
|
ANTALIS, TONI
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
PQ2 Obesity-induced fibrocytes promote breast cancer progression
|
1R01CA227542-01
|
$349,988
|
|
ARENDT, LISA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Cerenkov imaging for in vivo pH determination of the tumor microenvironment
|
5F31CA206453-03
|
$31,442
|
|
ARROYO PACHECO, ALEJANDRO
|
UNIVERSITY OF PENNSYLVANIA
|
|
Reversing Cellular immortality in cancer
|
5R35CA197563-04
|
$962,915
|
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
|
5R35CA197591-04
|
$977,640
|
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
Translating buccal nanocytology for lung cancer screening into clinical practice
|
1R01CA225002-01A1
|
$638,469
|
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Macrophage-Microbiota Interactions in Colon Cancer
|
1F31CA225044-01A1
|
$35,917
|
|
BADER, JACKIE
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
(PQC3) Ethnicity-determined immune response and DCIS outcome
|
5R01CA194600-04
|
$179,518
|
|
BADVE, SUNIL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Puerto Rico NCI Community Oncology Research Program Minority/Underserved
|
5UG1CA189862-05
|
$717,072
|
|
BAEZ- DIAZ, LUIS
|
COMPREHENSIVE CANCER CENTER/ UNIV/PR
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-05
|
$826,500
|
|
BAILEY, LISA
|
BAY AREA TUMOR INSTITUTE
|
|
Oncogenic Ras-induced macropinocytosis: A new paradigm for metabolic adaptation
|
5R35CA210263-03
|
$968,501
|
|
BAR-SAGI, DAFNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
A-to-I microRNA Editing and Melanoma Metastasis
|
1R21CA219958-01A1
|
$208,800
|
|
BARELI, MENASHE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Tumor Suppression by an African Specific Variant of p53
|
1F32CA220972-01A1
|
$59,038
|
|
BARNOUD, THIBAUT
|
WISTAR INSTITUTE
|
|
Ovarian Cancer Chemoprevention
|
5R01CA196200-04
|
$465,809
|
|
BENBROOK, DORIS
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
5R01CA188446-05
|
$765,486
|
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
Inter-regulatory function of immune-modulation and angiogenesis in cancer
|
5R01CA201537-03
|
$362,569
|
|
BERGERS, GABRIELE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Devaluing Energy-Dense Foods for Cancer Control: Translational Neuroscience
|
5R01CA211224-02
|
$705,027
|
|
BERKMAN, ELLIOT
|
UNIVERSITY OF OREGON
|
|
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
|
5R01CA197359-04
|
$388,875
|
|
BERLIN, JACOB
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
An assessment of whether aspirin and/or vitamin D improves breast cancer outcomes in Black women and the modifying effect of genetic variants
|
5K01CA212056-02
|
$133,775
|
|
BETHEA, TRACI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
5R01CA193220-04
|
$352,275
|
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
|
Combating Resistance to Antiangiogenic Therapy in Renal Cell Carcinoma
|
5R01CA196996-04
|
$398,025
|
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Development of 5hmC and 5mC biomarkers in cell-free circulating DNA for sensitive colon cancer detection and prognosis
|
5U01CA217078-02
|
$597,821
|
|
BISSONNETTE, BRUCE
|
UNIVERSITY OF CHICAGO
|
|
Elucidating the Mechanisms by which Hexokinase 2 Regulates Breast Cancer Metastasis
|
1F30CA228191-01
|
$49,524
|
|
BLAHA, CATHERINE
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
|
5R01CA204924-03
|
$657,305
|
|
BLASBERG, RONALD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
RPRD1B/Kub5/Hera, an RNA Pol II determinant that controls PARPi & IR sensitivity
|
5R01CA210489-04
|
$360,281
|
|
BOOTHMAN, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Defining and translating the properties that sustain the antitumor efficacy of Th17 cells
|
5F30CA200272-04
|
$46,154
|
|
BOWERS, JACOB
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.
|
5U54CA199081-04
|
$1,595,317
|
|
BRADBURY, MICHELLE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Protrusion plasticity during in vivo tumor cell migration
|
5K22CA196750-03
|
$192,240
|
|
BRAVO CORDERO, JOSE JAVIER
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Novel Role of REST in the Development of Pancreatic Ductal Adenocarcinoma
|
5F31CA220937-02
|
$39,223
|
|
BRAY, JULIE
|
UNIVERSITY OF FLORIDA
|
|
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer
|
2R01CA164719-06A1
|
$673,652
|
|
BRINDLEY, PAUL
|
GEORGE WASHINGTON UNIVERSITY
|
|
Inflammation, Physical Activity, and Colon Cancer Recurrence and Survival
|
5K99CA218603-02
|
$139,840
|
|
BROWN, JUSTIN
|
DANA-FARBER CANCER INST
|
|
Alliance NCORP Research Base
|
5UG1CA189823-05
|
$7,362,635
|
|
BUCKNER, JAN
|
MAYO CLINIC ROCHESTER
|
|
Using Technology to Scale-Up an Occupational Sun Protection Policy Program
|
5R01CA210259-02
|
$667,691
|
|
BULLER, DAVID
|
KLEIN BUENDEL, INC.
|
|
Stand and Move at Work: A Group-Randomized Trial
|
5R01CA198971-04
|
$582,484
|
|
BUMAN, MATTHEW
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Persistent HPV Infection in Women at Risk for Cervix Cancer
|
5U01CA078527-21
|
$581,591
|
|
BURK, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Mechanisms of Macrophage-Mediated Tumor Metastasis
|
5F30CA200133-05
|
$36,016
|
|
BURKARD, LAUREN
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Functional Genomics and Precision Therapy Testing for Langerhans Cell Histiocytosis
|
1F31CA228360-01
|
$44,524
|
|
BURKE, THOMAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Biological mechanisms involved with PDT in the treatment of MPM
|
5P01CA087971-15
|
$1,354,550
|
|
BUSCH, THERESA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$32,855
|
$329
|
Buxbaum, Nataliya
|
CCR (NCI)
|
Total relevant funding to Larynx for this search: $696,302
|